Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Lucid Group heads into its November earnings with short sellers sitting on a near-immovable position, the stock down another 6.5% on Wednesday to $3.89, and the lending pool still almost entirely dry.
The short book has barely shifted since last week's note, which is itself the story. Short interest holds at 28.4% of free float, up just 0.5% on the week but up 67% over the past month. The jump from roughly 55 million shares short at the start of September to 92 million now remains one of the more aggressive single-month short-building episodes on record for this name. What is striking is that established shorts have nowhere to go even if they wanted to cover quietly: days to cover per FINRA's latest fortnightly data runs at 8.1 days. The ORTEX short score has continued to creep higher, reaching 78.5 on Wednesday, its highest reading in the series shown and up from 77.6 two weeks ago. That drift higher reflects a position that is entrenching rather than turning.
The lending market is effectively closed to new shorts, which means the existing book is both trapped and crowded. Availability has spent every session for the past three weeks below 1%, hitting 0.03% as recently as October 2 before recovering slightly to 0.32% on Wednesday. At that level, roughly one share is available for every 313 already borrowed. Cost to borrow has edged up about 7% on the week to 7.6%, but remains far below the 12% level seen in late August, confirming that the bulk of the short book was established earlier and at cheaper rates. The ORTEX utilization rank sits at the 1st percentile relative to peers, the tightest in the entire coverage universe. The direction flag on availability is "rising," meaning supply is loosening fractionally at the margin, but 0.32% is not a figure that offers meaningful room for new entrants.
Options positioning has stayed persistently defensive throughout this episode, and this week is no different. The put/call ratio is 1.90, just above its 20-day average of 1.84, with a z-score of 0.46. That puts the reading in unremarkable territory relative to its own recent history, which is itself telling: a PCR that consistently sits near 1.9, well above the 52-week low of 0.90, reflects a market that has been buying downside protection as a baseline rather than as a reactive spike. The Street's direction of travel on targets has been consistently lower throughout 2026, with Citigroup cutting from $14 to $11 in August and RBC trimming to $7 in July, though Citigroup still carries a Buy. The mean price target of $7.94 is more than double the current price of $3.89, a gap that reflects either genuine long-term conviction or stale assumptions baked in before the Q1 delivery disaster. The ORTEX short score rank of 3rd percentile and utilization rank of 1st percentile together confirm the stock sits at an extreme in bearish positioning within its universe.
The institutional register adds one more layer of complexity to any squeeze narrative. Saudi Arabia's Public Investment Fund holds 44.9% of shares on the institutional register, and filed a Schedule 13D/A in April, confirming activist-level engagement. That is not a holder who sells into a bounce. Uber Technologies holds a further 9.6%, filed as a 13G passive stake in April. Prince Alwaleed Bin Talal added 19.5 million shares as recently as July, filing a fresh 13G/A in August. Between PIF, Uber, and Alwaleed, over 55% of the institutional register is effectively locked. That concentration constrains the free float and helps explain why availability has been unable to recover despite short interest stabilising. The insider register itself offers little signal: the only open-market activity in the past 90 days is a director selling 1,000 shares each month under a 10b5-1 plan, three trades totalling $16,380, a planned, mechanical disposal that says nothing about conviction.
The last two earnings prints delivered drops of 10.3% and 13% on the day, with five-day moves of roughly minus 16% and minus 13% respectively. The next event is November 6. With short interest entrenched at 28% of float and the lending pool near empty, the setup heading into that print is one where existing shorts are committed but finding it almost impossible to add, and any positive surprise would face a crowded exit with very little available borrow to absorb new short interest. What matters most between now and November 6 is whether delivery data for Q3, due before the print, shows any narrowing of the gap between Lucid's production capacity and actual customer demand.
See the live data behind this article on ORTEX.
Open LCID on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
